Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeiba Investme. Regulatory News (CBA)

Share Price Information for Ceiba Investme. (CBA)

Share Price is delayed by 15 minutes
Get Live Data
29.00    0.00 (0.00%)
Bid:
24.00
Ask:
34.00
Spread: 10.00 (41.667%)
Market Cap: £47.91m
CBA Live PriceLast checked at - London Stock Exchange

Intraday Ceiba Investme. Share Chart

Investment Update

17 Jan 2024 07:00

RNS Number : 8928Z
Ceiba Investments Limited
17 January 2024
 

17 January 2024

CEIBA INVESTMENTS LIMITED

(the "Company")

 

(TICKER CBA, ISIN: GG00BFMDJH11)

Legal Entity Identifier: 213800XGY151JV5B1E88

 

INVESTMENT UPDATE

 

On 14 January 2024, as part of the celebrations of the 510th anniversary of the founding of the UNESCO world heritage site of the city of Trinidad (Cuba), the Meliá Trinidad Peninsula Hotel was officially inaugurated by Cuba's Prime Minister Manuel Marrero, the Minister of Tourism Juan Carlos García and Gabriel Escarrer, the President of Spain's Meliá Hotels International S.A.

 

The 401-room 5-star beach resort hotel is located on prime beachfront property within easy reach of the historic city of Trinidad, the Valle de los Ingenios and the natural beauty of the Escambray mountain range. It is the first joint venture hotel to be constructed in Cuba in many years. The Company provided the majority of the finance for this project and holds a 32.5% indirect interest in the hotel alongside Cuba's tourism company CUBANACAN S.A. (50%) and Meliá Hotels International S.A. (17.5%).

 

John Herring, Chairman of the Company commented:

 

"We are very pleased to announce that this marvellous hotel, which was constructed during the Covid pandemic and experienced many serious headwinds over the years, has now been officially opened. Without a doubt, our investment commitments have resulted in the creation of one of Cuba's best hotels.

 

We are optimistic on the timeline to recover our investment and we are proud of our team in Cuba, who played a vital role in completing the project in difficult circumstances, as well as of our Cuban and Spanish partners for reaching this important milestone."

 

The Meliá Trinidad Peninsula Hotel is an international 5-star luxury beach resort hotel situated on a 6-hectare beachfront property, located some 5 kilometres from the city of Trinidad, Cuba. Constructed over three stories, it is a state-of-the-art resort featuring numerous swim-up pools, smart technology, 14 restaurants and bars and a YHI Spa. A substantial portion of the energy consumed by the hotel is generated on-site and stored through extensive combined solar panel and battery pack installations.

 

The total cost of the project was approximately US$79 million, including US$16 million in share capital invested in TosCuba by the shareholders, of which the Company has an interest of US$5.2 million (32.5%), more than US$11 million in grants received under the Spanish Cuban Debt Conversion Programme, and US$51.5 million disbursed under a construction finance facility under which the Company has a US$41million total participation (US$36.125 million in direct participations and US$4.875 million as part of its 65% interest in Homasi S.A.). Debt service in favour of the Company under the construction finance facility is scheduled to begin in the second quarter of 2024.

 

For reservations visit https://www.meliacuba.com/en/destinations/trinidad/hotels/melia-trinidadpeninsula

 

For further information, please contact:

 

Sebastiaan Berger 

Via NSM Funds Limited

Singer Capital Markets James Maxwell / Finn Gordon (Corporate Finance)James Waterlow (Sales)

 

Tel: +44 (0)20 7496 3000

NSM Funds Limited

Tel: +44 (0)1481 743030

 www.ceibainvest.com

 END OF ANNOUNCEMENT

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDZZGMMVVGGDZM
12
Date   Source Headline
5th Jun 20268:33 amRNSTrading Update
27th May 20263:39 pmRNSHolding(s) in Company
22nd May 20262:30 pmRNSHolding(s) in Company
20th May 20263:37 pmRNSHolding(s) in Company
19th May 20261:07 pmRNSHolding(s) in Company
15th May 202612:40 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSIssue of Equity
30th Apr 20267:00 amRNSAnnual Financial Report
14th Apr 20264:46 pmRNSResult of EGM
1st Apr 202611:21 amRNSFurther re Second Amendment of Bond Instrument
27th Feb 20265:14 pmRNSFurther re Second Amendment of Bond Instrument
27th Feb 20262:26 pmRNSDirectorate change
13th Feb 20265:13 pmRNSStatement re Second Amendment of Bond Instrument
13th Feb 20263:20 pmRNSDirector Declaration
12th Feb 20265:32 pmRNSChange of Auditor
5th Feb 20267:00 amRNSTrading Update - Consultation with Bondholders
26th Jan 20263:36 pmRNSDirector/PDMR Shareholding
23rd Dec 20251:39 pmRNSNet Asset Value(s)
4th Dec 20253:25 pmRNSAppointment of Senior Independent Director
2nd Oct 20252:48 pmRNSDirector/PDMR Shareholding
29th Sep 20257:00 amRNSHalf-year Report
12th Sep 20253:16 pmRNSDirectorate Change
8th Jul 20257:00 amRNSTrading Update - Payment to Bondholders
4th Jul 202512:49 pmRNSDirectorate Change
3rd Jul 20253:14 pmRNSResult of AGM
1st Jul 20251:35 pmRNSNet Asset Value(s)
30th Apr 20257:00 amRNSAnnual Financial Report
28th Apr 202510:26 amRNSDirectorate Change
3rd Feb 20257:00 amRNSStatement re Amendment of Bond Instrument
13th Jan 20255:51 pmRNSStatement re Amendment of Bond Instrument
11th Dec 20241:31 pmRNSNet Asset Value(s)
7th Oct 202410:55 amRNSDirector/PDMR Shareholding
7th Oct 20247:00 amRNSStatement re Update from the Chairman
27th Sep 20247:00 amRNSHalf-year Report to 30 June 2024
13th Aug 20248:36 amRNSDirectorate Change
20th Jun 20243:09 pmRNSDirector/PDMR Shareholding
20th Jun 20247:00 amRNSNet Asset Value(s)
18th Jun 20244:53 pmRNSResult of AGM
30th Apr 20247:00 amRNSAnnual Financial Report
25th Mar 202411:03 amRNSDirectorate Change
17th Jan 20247:00 amRNSInvestment Update
27th Dec 20239:17 amRNSNet Asset Value(s)
18th Dec 20238:54 amRNSDirector/PDMR Shareholding
3rd Nov 202310:36 amRNSHolding(s) in Company
1st Nov 20239:05 amRNSDirector/PDMR Shareholding
27th Oct 202311:11 amRNSDirector/PDMR Shareholding
16th Oct 20238:37 amRNSAppointment of Non-Executive Director
12th Oct 20234:26 pmRNSDirector/PDMR Shareholding
5th Oct 202310:24 amRNSDirector/PDMR Shareholding
29th Sep 20237:00 amRNSHalf-year Report
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.